Mie Study of Clopidogrel Low Responder in Atherothrombotic Disease Patients with/without Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 25 Aug 2016
At a glance
- Drugs Clopidogrel (Primary)
- Indications Cerebral infarction; Coronary disorders; Embolism and thrombosis
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms McLORDD
- 23 Aug 2016 Status changed from active, no longer recruiting to completed.
- 16 Jun 2013 Planned End Date changed from 1 Mar 2013 to 30 May 2014 as reported by University Hospital Medical Information Network - Japan.
- 16 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.